The purpose of the present invention is to provide a glucokinase activator useful as a pharmaceutical agent such as an agent for the prophylaxis or treatment of diabetes, obesity and the like. The present invention provides a glucokinase activator containing a compound represented by the formula (I):wherein R<SUP>1</SUP> is a hydrogen atom or a halogen atom; R<SUP>2</SUP> is a group represented by wherein each symbol is defined in the specification, or a salt thereof or a prodrug thereof.
申请公布号
WO2008050821(A1)
申请公布日期
2008.05.02
申请号
WO2007JP70772
申请日期
2007.10.18
申请人
TAKEDA PHARMACEUTICAL COMPANY LIMITED;YASUMA, TSUNEO;UJIKAWA, OSAMU;ITOH, MASAHIRO;AOKI, KAZUKO